[Skip to Content]
[Skip to Content Landing]
Views 390
Citations 0
Comment & Response
April 2014

Optimizing the Impact of Drugs on Symptom Burden in Older People With Multimorbidity at the End of Life

Author Affiliations
  • 1Faculty of Pharmacy and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • 2Royal North Shore Hospital, Kolling Institute of Medical Research and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
 

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2014;174(4):636-637. doi:10.1001/jamainternmed.2013.12875

To the Editor We commend Chaudhry et al1 on their excellent article that reported high prevalence of symptoms that negatively affect functioning and quality of life in a cohort of older community-dwelling people with multimorbidity and a life expectancy of less than 1 year.

In older people, mulitimorbidity often coexists with polypharmacy, commonly defined as the use of 5 or more drugs. In her Invited Commentary, Ritchie2 highlights that pharmacological treatment of 1 symptom may exacerbate another or a coexisting condition, which may in part explain the increase in symptoms in this population.

×